VALERIE KOLBERT: Open Payments
NPI 1902994510 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,367 in 100 payments from 13 companies in 2025. Trend: 2023 $3,637 · 2024 $3,960 · 2025 $3,367
Food & beverage: $3,367
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 25 | $687 |
| Teva Pharmaceuticals USA, Inc. | 15 | $609 |
| Vanda Pharmaceuticals Inc. | 13 | $541 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $397 |
| Alkermes, Inc. | 9 | $286 |
| ABBVIE INC. | 4 | $205 |
| Supernus Pharmaceuticals, Inc. | 4 | $189 |
| Janssen Pharmaceuticals, Inc | 4 | $157 |
| Axsome Therapeutics, Inc. | 1 | $112 |
| E.R. Squibb & Sons, L.L.C. | 2 | $87 |
Products named: INGREZZA, AUSTEDO XR, CAPLYTA, FANAPT, HETLIOZ, VRAYLAR, Qelbree, LYBALVI.
Industry payments across FL — which companies pay providers there.
